BROSHY ERAN (CIK 1256230) reported 11 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-05-15). Recent activity: Buy CERT (15,757 shares), Sell TBPH (14,000 shares), Sell TBPH (15,501 shares), Sell TBPH (15,500 shares), Sell TBPH (15,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-15 | Certara, Inc. (CERT) | Director | Buy | 15,757 | $0 |
| 2025-12-01 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 14,000 | $280,000 |
| 2025-12-01 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 15,501 | $310,020 |
| 2025-11-14 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 15,500 | $286,750 |
| 2025-11-14 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 15,500 | $263,500 |
| 2025-11-14 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 14,000 | $259,000 |
| 2025-11-13 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 29,500 | $545,750 |
| 2025-11-13 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 15,500 | $263,500 |
| 2025-11-13 | Theravance Biopharma, Inc. (TBPH) | Director | Sell | 14,000 | $259,000 |
| 2025-05-22 | Certara, Inc. (CERT) | Director | Buy | 11,928 | $0 |
| 2025-05-21 | Theravance Biopharma, Inc. (TBPH) | Director | Buy | 10,649 | $0 |
Source: SEC Form 4 filings · as of 2026-05-15